squamous cell cancer
Showing 1 - 18 of 18
Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer Trial in Boise (30% ascorbic acid in DMSO)
Recruiting
- Squamous Cell Cancer
- +3 more
- 30% ascorbic acid in DMSO
-
Boise, IdahoCenter for Biomedical Research,Inc.
Jul 2, 2023
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
-
Tampa, Florida
- +2 more
Dec 30, 2022
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
PET-CT for Squamous Cell Carcinoma of Neck Nodes Unknown Primary
Completed
- Squamous Cell Cancer
- PET-CT
-
Calgary, Alberta, CanadaTom Baker Cancer Centre
Oct 17, 2019
Squamous Cell Cancer, Head Neck Cancer Trial in United States (Temsirolimus + Weekly Paclitaxel + Carboplatin)
Completed
- Squamous Cell Cancer
- Head and Neck Cancer
- Temsirolimus + Weekly Paclitaxel + Carboplatin
-
Basking Ridge, New Jersey
- +4 more
Jun 3, 2019
Head and Neck, Squamous Cell Cancer Trial in United States (cetuximab)
Completed
- Head and Neck
- Squamous Cell Cancer
- cetuximab
-
Duarte, California
- +16 more
Dec 11, 2017
Head Neck Cancer, Squamous Cell Cancer Trial in Basking Ridge, New York (Afatinib, Ribavirin, and weekly carboplatin/paclitaxel)
Completed
- Head and Neck Cancer
- Squamous Cell Cancer
- Afatinib, Ribavirin, and weekly carboplatin/paclitaxel
-
Basking Ridge, New Jersey
- +1 more
Oct 23, 2017
Squamous Cell Cancer Trial in Durham (Sorafenib, Cetuximab)
Completed
- Squamous Cell Cancer
-
Durham, North CarolinaDuke University Health System
Dec 5, 2014
Head Neck Cancer, Squamous Cell Cancer Trial in Worldwide (Zalutumumab)
Completed
- Head and Neck Cancer
- Squamous Cell Cancer
-
Birmingham, Alabama
- +47 more
Aug 12, 2014
Squamous Cell Cancer Trial in Worldwide (Cilengitide 2000 mg once weekly, Cilengitide 2000 mg twice weekly, Cetuximab)
Completed
- Squamous Cell Cancer
- Cilengitide 2000 mg once weekly
- +4 more
-
Salzburg, Austria
- +36 more
Mar 28, 2014
Head and Neck Squamous Cell Carcinoma to Therapy
Completed
- Head and Neck Cancer
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai, Otolaryngology - Head a
Apr 8, 2014
Head Neck Cancer, Squamous Cell Cancer Trial in Worldwide (Zalutumumab, Control)
Completed
- Head and Neck Cancer
- Squamous Cell Cancer
- Zalutumumab
- Control
-
Antwerp, Belgium
- +81 more
Aug 9, 2013
Head Neck Cancer, Squamous Cell Cancer Trial in Houston (Imatinib Mesylate, Docetaxel)
Completed
- Head and Neck Cancer
- Squamous Cell Cancer
- Imatinib Mesylate
- Docetaxel
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Aug 1, 2012
Head Neck Cancer, Squamous Cell Cancer Trial in Worldwide (zalutumumab, cisplatin, Radiotherapy)
Terminated
- Head and Neck Cancer
- Squamous Cell Cancer
- zalutumumab
- +2 more
-
Portland, Oregon
- +6 more
Nov 21, 2011
Squamous Cell Cancer, Cancer of Head and Neck Trial in London (gefitinib, cisplatin, 5-flourouracil)
Completed
- Squamous Cell Cancer
- Cancer of Head and Neck
- gefitinib
- +2 more
-
London, United KingdomResearch Site
Apr 22, 2009
Esophageal Tumors, Squamous Cell Cancer Trial in Lublin (procedure, drug, radiation)
Terminated
- Esophageal Neoplasms
- Squamous Cell Cancer
- transthoracic esophagectomy 2-field extended lymphadenectomy
- +2 more
-
Lublin, Lubelskie, Poland2nd Department of General, Gastrointestinal Surgery & Surgical O
Nov 15, 2007